Dang W, Li Q, Wang X
BMC Cancer. 2025; 25(1):191.
PMID: 39901207
PMC: 11789379.
DOI: 10.1186/s12885-025-13592-4.
Desterke C, Fu Y, Bonifacio-Mundaca J, Monge C, Pineau P, Mata-Garrido J
Curr Oncol. 2025; 32(1).
PMID: 39851951
PMC: 11763369.
DOI: 10.3390/curroncol32010035.
Yu X, Sarabia S, Urbicain M, Somvanshi S, Patel R, Tran T
bioRxiv. 2025; .
PMID: 39763896
PMC: 11703271.
DOI: 10.1101/2024.12.24.630261.
Requena D, Medico J, Soto-Ugaldi L, Shirani M, Saltsman 3rd J, Torbenson M
Nat Commun. 2024; 15(1):10887.
PMID: 39738196
PMC: 11685927.
DOI: 10.1038/s41467-024-55238-2.
Monge C, Frances R, Marchio A, Pineau P, Desterke C, Mata-Garrido J
Int J Mol Sci. 2024; 25(23).
PMID: 39684755
PMC: 11641740.
DOI: 10.3390/ijms252313044.
IsopretGO-analysing and visualizing the functional consequences of differential splicing.
Karlebach G, Hansen P, Kohler K, Robinson P
NAR Genom Bioinform. 2024; 6(4):lqae165.
PMID: 39660256
PMC: 11630322.
DOI: 10.1093/nargab/lqae165.
A developmental biliary lineage program cooperates with Wnt activation to promote cell proliferation in hepatoblastoma.
Wu P, Fish M, Hazard F, Zhu C, Vennam S, Walton H
Nat Commun. 2024; 15(1):10007.
PMID: 39567523
PMC: 11579301.
DOI: 10.1038/s41467-024-53802-4.
Divergent WNT signaling and drug sensitivity profiles within hepatoblastoma tumors and organoids.
Kluiver T, Lu Y, Schubert S, Kraaier L, Ringnalda F, Lijnzaad P
Nat Commun. 2024; 15(1):8576.
PMID: 39567475
PMC: 11579375.
DOI: 10.1038/s41467-024-52757-w.
Gamma-butyrobetaine hydroxylase (BBOX1) exerts suppressive effects on HepG2 hepatoblastoma cells.
Zhan Y, Dong X, Yang M, Li S, Ou M, Wang Y
Med Oncol. 2024; 41(11):253.
PMID: 39331195
DOI: 10.1007/s12032-024-02496-1.
First Transcriptome Analysis of Hepatoblastoma in Brazil: Unraveling the Pivotal Role of Noncoding RNAs and Metabolic Pathways.
Aguiar T, Rivas M, Silva E, Pires S, Dangoni G, Macedo T
Biochem Genet. 2024; .
PMID: 38649558
DOI: 10.1007/s10528-024-10764-y.
Single-cell multiomics reveals the interplay of clonal evolution and cellular plasticity in hepatoblastoma.
Roehrig A, Hirsch T, Pire A, Morcrette G, Gupta B, Marcaillou C
Nat Commun. 2024; 15(1):3031.
PMID: 38589411
PMC: 11001886.
DOI: 10.1038/s41467-024-47280-x.
Summary of biological research on hepatoblastoma: a scoping review.
Wang H, Lao J, Jiang R, Wang B, Ma X, Wang J
Front Pediatr. 2024; 12:1309693.
PMID: 38390281
PMC: 10881832.
DOI: 10.3389/fped.2024.1309693.
EZH2 is a key component of hepatoblastoma tumor cell growth.
Glaser K, Schepers E, Zwolshen H, Lake C, Timchenko N, Karns R
Pediatr Blood Cancer. 2023; 71(2):e30774.
PMID: 37990130
PMC: 10842061.
DOI: 10.1002/pbc.30774.
Preneoplastic liver colonization by 11p15.5 altered mosaic cells in young children with hepatoblastoma.
Pilet J, Hirsch T, Gupta B, Roehrig A, Morcrette G, Pire A
Nat Commun. 2023; 14(1):7122.
PMID: 37932266
PMC: 10628292.
DOI: 10.1038/s41467-023-42418-9.
Ferroptosis regulator NOS2 is closely associated with the prognosis and cell malignant behaviors of hepatoblastoma: a bioinformatic and study.
Zhang L, Ren B, Wei F, Liu Y, Gao Y, Yuan B
Front Oncol. 2023; 13:1228199.
PMID: 37795447
PMC: 10546316.
DOI: 10.3389/fonc.2023.1228199.
Children's Oncology Group's 2023 blueprint for research: Liver tumors.
ONeill A, Meyers R, Katzenstein H, Geller J, Tiao G, Lopez-Terrada D
Pediatr Blood Cancer. 2023; 70 Suppl 6:e30576.
PMID: 37495540
PMC: 10529117.
DOI: 10.1002/pbc.30576.
Genome-wide mapping of cancer dependency genes and genetic modifiers of chemotherapy in high-risk hepatoblastoma.
Fang J, Singh S, Cheng C, Natarajan S, Sheppard H, Abu-Zaid A
Nat Commun. 2023; 14(1):4003.
PMID: 37414763
PMC: 10326052.
DOI: 10.1038/s41467-023-39717-6.
expression is elevated in hepatoblastoma and correlates with inferior patient survival.
Nousiainen R, Eloranta K, Isoaho N, Cairo S, Wilson D, Heikinheimo M
Front Genet. 2023; 14:1170940.
PMID: 37377594
PMC: 10291054.
DOI: 10.3389/fgene.2023.1170940.
GepLiver: an integrative liver expression atlas spanning developmental stages and liver disease phases.
Li Z, Zhang H, Li Q, Feng W, Jia X, Zhou R
Sci Data. 2023; 10(1):376.
PMID: 37301898
PMC: 10257690.
DOI: 10.1038/s41597-023-02257-1.
Antagonism between wild-type and mutant β-catenin controls hepatoblastoma differentiation via fascin-1.
Gest C, Sena S, Dif L, Neaud V, Loesch R, Dugot-Senant N
JHEP Rep. 2023; 5(5):100691.
PMID: 37153687
PMC: 10159820.
DOI: 10.1016/j.jhepr.2023.100691.
